Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Free Cash Flow (2019 - 2025)

Silo Pharma's Free Cash Flow history spans 7 years, with the latest figure at -$955493.0 for Q3 2025.

  • For Q3 2025, Free Cash Flow rose 29.04% year-over-year to -$955493.0; the TTM value through Sep 2025 reached -$4.8 million, down 25.4%, while the annual FY2024 figure was -$3.8 million, 18.9% down from the prior year.
  • Free Cash Flow for Q3 2025 was -$955493.0 at Silo Pharma, up from -$1.3 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$319318.0 in Q1 2021 and bottomed at -$1.6 million in Q1 2025.
  • The 5-year median for Free Cash Flow is -$838179.0 (2024), against an average of -$879742.7.
  • The largest annual shift saw Free Cash Flow crashed 171.51% in 2021 before it grew 29.04% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$773871.0 in 2021, then decreased by 14.49% to -$885989.0 in 2022, then decreased by 2.71% to -$910012.0 in 2023, then fell by 0.82% to -$917432.0 in 2024, then decreased by 4.15% to -$955493.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Free Cash Flow are -$955493.0 (Q3 2025), -$1.3 million (Q2 2025), and -$1.6 million (Q1 2025).